Trademark Overview
On Wednesday, April 15, 2026, a trademark application was filed for PRWE with the United States Patent and Trademark Office. The USPTO has given the PRWE trademark a serial number of 99765776. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 15, 2026. This trademark is owned by Atropos Health, Inc.. The PRWE trademark is filed in the Advertising, Business and Retail Services, Communication Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific and technological services, including the design, development, and implementation of proprietary study designs and analytical methodologies (e.g., Prognostogram, Pathways) to generate, synthesize, and validate large volumes of precision real world evidence, including comprehensive narrative summaries of clinical outcomes, from real-world data sources; providing non-downloadable computer software platforms for the creation, organization, tagging, and management of internal and external healthcare evidence, including the generation and storage of precision real world evidence for use in clinical research and analytics; providing curated, personalized, and cited precision real world evidence, comprising peer-reviewable narrative summaries synthesizing clinical outcomes, specifically designed as primary training material to inform and benchmark large language models (LLMs) and artificial intelligence (AI) in the healthcare domain
Providing medical and clinical information services, including the synthesis of a patient's clinical journey and the surfacing of relevant evidence in narrative summary form, through the delivery of precision real world evidence to inform personalized medicine, patient risk stratification, and patient care decisions at the point of care; providing health outcome and medical analysis services, including the quantification of risk and the monitoring of outcomes per case, based on large-scale, personalized precision real world evidence to support providers, payers, and patients
Providing business consulting, management, and administrative services in the healthcare industry, utilizing precision real world evidence for strategic planning, operational efficiency, and evidence-based decision-making for healthcare providers, payers, and pharmaceutical companies; providing business intelligence and predictive data analysis services, including the creation of custom content packages and market share analysis, using precision real world evidence to inform formulary guidance, medical benefit positions, and commercial analytics; business advisory services focused on healthcare cost containment, precision adjudication of high-cost therapies, and streamlining prior authorization processes by applying large-scale, personalized precision real world evidence
Electronic transmission of data, documents, and digital content, specifically personalized and highly granular precision real world evidence summaries and reports, including in document formats, to facilitate shared decision-making, provider care assistance, and commercial analytics; providing telecommunications access to a proprietary library and database of novel studies and precision real world evidence for both human and automated consumption, including the provision of application programming interfaces (APIs) for data access
